Vector BioMed

Lentiviral Vector Design and Manufacturing

United States · $15.0M raised

Business Model
B2B
Total Funding
$15.0M
Last Round
$15.0M SeedJan 2023
Rounds
1

About

Vector BioMed provides lentiviral-vector design and manufacturing intended to lower barriers to gene-therapy development through rapid, innovative, and affordable capabilities. Its scientists, engineers, and industry veterans bring experience in vector development, regulatory strategy, and clinical translation. The company collaborates with biotechnology companies, research institutions, and global-health organizations to advance gene and cell therapies toward accessible treatments.

Summary

Vector BioMed is a Biotech company based in United States. It has raised $15.0M in total across 1 round, most recently a $15.0M Seed round in Jan 2023. Investors include Viking Global and Casdin Capital.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2023
$15.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vector BioMed on Indexed.vc
<a href="https://indexed.vc/companies/vector-biomed"><img src="https://indexed.vc/api/badge/company/vector-biomed" alt="Vector BioMed on Indexed.vc" width="260" height="76" /></a>